Genomics

Dataset Information

Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling [Affymetrix]


ABSTRACT: Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling [Affymetrix]

PROVIDER: PRJNA430776 | ENA |

REPOSITORIES: ENA